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Abstract 
BACKGROUND: A case of testicular cancer treated with neo adjuvant therapy in a patient in male is rare. When 
testicular cancer presents, it is usually directly operated due to the size of cancer which presented within the order 
of operable size.  
CASE PRESENTATION: Here, we report a rare case of a 5-year-old male patient presented to the emergency 
room (ER) due to mass on the scrotum without the difficulty of urination. From clinical findings, mass with a size of 
15 x 10 cm was found with multiple abscesses on both sides of the scrotum. Pathological Anatomy Examination 
confirmed yolk sac tumour present within the scrotal mass. Initially, palliative chemotherapy took place to reduce 
the growth rate of the tumour. However, due to the responsiveness of testicular cancer to chemotherapy drugs, it 
reduced into operable size testicular cancer. Wide excision and Orchidectomy was then performed, followed by 
adjuvant chemotherapy. 
CONCLUSION: This case report showed the possibility of using neo adjuvant chemotherapy as an alternative 
treatment when inoperable testicular cancer presented in hospital. 
 
 
 
 
 
Introduction 
 
In children, testicular tumours are uncommon, 
with an incidence of approximately 0.5 – 2.0 per 
100,000 individuals and comprise about 1 – 2% of 
pediatric malignancies [1], [2], [3]. One study 
suggested that testicular tumours may be more 
common in Asian than in Caucasian children [4]. 
Testicular cancer represents the most 
common malignancy in males aged 15-34 years [5]. 
Histopathologically, testicular germ cell tumours are 
divided into two major groups: pure seminoma and 
nonseminoma. The pathogenesis of testicular germ 
cell tumours remains unknown; however, although 
recently questioned [6], cryptorchidism is the main risk 
factor, and molecular studies have shown strong 
evidence of an association between genetic 
alterations and testicular germ cell tumours [7]. Nearly 
40% of the cases correspond to seminomas, and 
three-quarters of them are diagnosed with stage I of 
the disease [5]. Although testicular cancer has 
excellent cure rates, the choice of treatment centre is 
of utmost importance. Expert centres achieve better 
results for both the early-stage testicular cancer (lower 
relapse rates) and overall survival (higher stages 
within clinical trials) [8]. 
Seminomas are more sensitive to 
chemotherapy and radiation therapy; therefore, they 
are easier to cure than non-seminomas. The surgical 
treatment is either orchiectomy or orchidectomy plus 
lymph node dissection of the involved ganglia followed 
by adjuvant chemotherapy. Testicular cancer treated 
with neo adjuvant therapy was rare, due to the 
operable size of commonly found testicular cancer. 
 
 
Case Report 
 
A 5-year-old Indonesian male with a size of 
15 x 10 cm soft tissue mass with multiple abbesses on 
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both side of the scrotum was presented to the 
emergency room. The patient stated that the lesion 
had been presented for 2 years. It appeared initially 
as an itchy mass appeared on the left side of the 
scrotum and grew bigger. The overlying skin surface 
was presented with erythema, multiple abscesses and 
sinus tracts. The lesion was indurated and tender 
(Figure 1). The bilateral testis cannot be identified 
even though penile and meatal can be identified. The 
patient had no difficulty of micturition. 
 
Figure 1: Lesion of the Scrotum Pre 
 
Secondary examinations such as blood test 
as well as Ultrasonography, Chest x-ray and 
Computed Tomography (CT) scan was performed to 
the scrotum. The blood test result showed increased 
zero marker value, which ensured the presence of 
testicular cancer. Ultrasonography of the scrotum 
showed enlargement of the left testis while right testis 
was found within normal limit. Abdominal CT-scan 
examination also showed enlargement on the left 
testis but limited only to the scrotum (Figure 5).  
 
Figure 2: Lesion of the Scrotum Post Neo Adjuvant 
 
Chest x-ray showed coin lesion as it was 
already metastasised to the lungs. Based on the 
examination results, we decided to do palliative 
chemotherapy due to the inoperable size of testicular 
cancer.  
 
Figure 3: Lesion of the Scrotum Post 
However, after four chemotherapy treatments, 
the size of testicular cancer was significantly reduced 
to operable size (Figure 2) as it was confirmed by the 
abdominal CT-scan (Figure 6).  
 
Figure 4: Lesion of the Scrotum Post Adjuvant Chemotherapy 
 
Therefore, we decided to do wide excision 
and orchidectomy on the left testis (Figure 3). 
Lymphadenectomy was also done in conjunction with 
previous surgery to remove an enlarged lymph node. 
It was then followed by four times adjuvant 
chemotherapy. 
 
Figure 5: Computed Tomography of Lower Abdomen Pre 
 
One month after the last chemotherapy, a 
patient came control to the outpatient clinic. The 
scrotum was appeared to be within normal limit. There 
was neither induration nor tenderness found in the 
scrotum.  
 
Figure 6: Computed Tomography of Lower Abdomen Post Neo 
Adjuvant 
 
The overlying skin surface was also 
presented within the normal limit (Figure 4). A chest x-
ray also showed lungs within normal limit. 
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Figure 7: Chest X-Ray Pre 
 
 
 
Discussion 
 
This case suggested neo adjuvant 
chemotherapy usage in inoperable testicular cancer. 
The patient was delayed in presentation due to limited 
access to appropriate medical facilities as well as the 
patient’s ignorance of the massive scrotal swelling 
that had been persisting for at least 12 months. In this 
case, the inoperable scrotal mass was then presented 
with multiple abscesses in the emergency room. 
 
Figure 8: Chest X-Ray Post Operation 
 
A review of the literature showed that this 
form of presentation is rare [9], [10], [11]. Although the 
recent diagnostic and therapeutic developments have 
altered the prognosis in this disease, the delay in 
diagnosis and occasional mismanagement of patients 
continue to inhibit further improvement in survival rate. 
A high index of suspicion and an aggressive approach 
to its management are advocated to improve long-
term survival [12]. 
Testicular cancer has a higher 
responsiveness to chemotherapy compared to other 
cancer. The key to such success appears to lie in 
cancer's stem cells, which are more sensitive to 
chemotherapy than stem cells found in other types of 
cancer. Defining why testicular cancers are so 
susceptible to chemotherapy could eventually provide 
insights for treating other, more resistant cancers [13].
 
Most types of tumours contain distinct 
populations of cells. A small fraction of these is stem 
cells, which can grow new tumours from a single cell 
and are extremely resistant to therapy. Often, other 
types of tumour cells are killed off during treatment, 
but cancer stem cells survive, then drive relapse by 
re-growing new tumours. However, when testicular 
cancer stem cells are exposed to chemotherapy, 
those stem cells are more sensitive to it than other 
cells in the tumour [14]. 
The use of neo adjuvant chemotherapy has 
led to a dramatic improvement in the cure rate of 
patients with metastatic germ cell tumours (GCTs). 
The high responsiveness of testicular cancer was 
achieved even in inoperable size of testicular cancer. 
After that, the goals of the patient changed from 
palliative into curative by the introduction of neo 
adjuvant chemotherapy, followed by surgical 
treatment and adjuvant chemotherapy. 
In conclusion, testicular cancer treated with 
neoadjuvant chemotherapy is unusual as the 
mainstay treatment for testicular cancer is directly 
surgical and followed by adjuvant chemotherapy. This 
case presented the inoperable size of testicular 
cancer in which palliative chemotherapy takes place 
to reduce the growth rate of testicular cancer. 
However, due to the responsiveness of testicular 
cancer to chemotherapy agent, it reduced the initial 
size into an operable size, which later on able to 
follow the treatment stated in guidelines. This case 
report showed the possibility of using neo adjuvant 
chemotherapy as an alternative treatment when 
inoperable testicular cancer presented in hospital. 
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